Molflu is expected to be available from early next week in pharmacies throughout the country, Dr. Reddy’s said
Pharma major Dr. Reddy’s Laboratories on Tuesday said it would launch molnupiravir capsules 200 mg, the anti-viral drug that India recently granted emergency use authorisation for COVID-19 treatment, at ₹35 each under the brand name Molflu.
Each strip would have 10 capsules. With the recommended dose 800 mg twice a day for five days, the total course of 40 capsules would cost ₹1,400, making it among the most affordable treatment options available to patients, Dr. Reddy’s said.